Literature DB >> 2989559

DNA-binding proteins present in varicella-zoster virus-infected cells.

C R Roberts, A C Weir, J Hay, S E Straus, W T Ruyechan.   

Abstract

DNA-binding proteins present in varicella-zoster virus-infected cells were identified by DNA-cellulose chromatography of radioactively labeled cell extracts. Seven virus-specific proteins, ranging in molecular weight from approximately 175,000 to 21,000, showed affinity for single- or double-stranded DNA or both. These proteins include the varicella-zoster virus major capsid protein, a phosphorylated tegument protein, and a 125,000-molecular-weight species which may be analogous to the major DNA-binding protein of herpes simplex virus. We also identified a number of DNA-binding phosphoproteins by these procedures. Finally, protein blot studies were carried out to determine whether these proteins bind preferentially to virus rather than to host cell DNA.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989559      PMCID: PMC254896     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Herpes simplex virus proteins: DNA-binding proteins in infected cells and in the virus structure.

Authors:  G J Bayliss; H S Marsden; J Hay
Journal:  Virology       Date:  1975-11       Impact factor: 3.616

2.  DNA-binding proteins of cells infected by herpes simplex virus type 1 and type 2.

Authors:  K L Powell; D J Purifoy
Journal:  Intervirology       Date:  1976       Impact factor: 1.763

3.  DNA-binding proteins induced by herpes simplex virus type 2 in HEp-2 cells.

Authors:  D J Purifoy; K L Powell
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

4.  Control of protein synthesis in herpesvirus-infected cells: analysis of the polypeptides induced by wild type and sixteen temperature-sensitive mutants of HSV strain 17.

Authors:  H S Marsden; I K Crombie; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1976-06       Impact factor: 3.891

5.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

6.  Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map.

Authors:  S M Brown; D A Ritchie; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1973-03       Impact factor: 3.891

7.  Temperature-sensitive mutants of herpes simplex virus type 2.

Authors:  M C Timbury
Journal:  J Gen Virol       Date:  1971-11       Impact factor: 3.891

8.  Proteins specified by herpes simplex virus. Staining and radiolabeling properties of B capsid and virion proteins in polyacrylamide gels.

Authors:  W Gibson; B Roizman
Journal:  J Virol       Date:  1974-01       Impact factor: 5.103

9.  Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion.

Authors:  P G Spear; B Roizman
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

10.  Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains.

Authors:  J W Heine; R W Honess; E Cassai; B Roizman
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

View more
  14 in total

1.  A sequence within the varicella-zoster virus (VZV) OriS is a negative regulator of DNA replication and is bound by a protein complex containing the VZV ORF29 protein.

Authors:  Mohamed I Khalil; Ann Arvin; Jeremy Jones; William T Ruyechan
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  The early UL31 gene of equine herpesvirus 1 encodes a single-stranded DNA-binding protein that has a nuclear localization signal sequence at the C-terminus.

Authors:  Seongman Kim; Byung Chul Ahn; Dennis J O'Callaghan; Seong Kee Kim
Journal:  Virology       Date:  2012-06-20       Impact factor: 3.616

3.  Identification and characterization of a varicella-zoster virus DNA-binding protein by using antisera directed against a predicted synthetic oligopeptide.

Authors:  P R Kinchington; G Inchauspe; J H Subak-Sharpe; F Robey; J Hay; W T Ruyechan
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

4.  The cellular localization pattern of Varicella-Zoster virus ORF29p is influenced by proteasome-mediated degradation.

Authors:  Christina L Stallings; Gregory J Duigou; Anne A Gershon; Michael D Gershon; Saul J Silverstein
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Transcription mapping of the varicella-zoster virus genome.

Authors:  J M Ostrove; W Reinhold; C M Fan; S Zorn; J Hay; S E Straus
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

6.  Dissection of a novel nuclear localization signal in open reading frame 29 of varicella-zoster virus.

Authors:  Christina L Stallings; Saul Silverstein
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Mapping of transcriptional regulatory domains of pseudorabies virus immediate-early protein.

Authors:  S Taharaguchi; H Inoue; E Ono; H Kida; S Yamada; Y Shimizu
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  The conserved DNA-binding domains encoded by the herpes simplex virus type 1 ICP4, pseudorabies virus IE180, and varicella-zoster virus ORF62 genes recognize similar sites in the corresponding promoters.

Authors:  C L Wu; K W Wilcox
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor.

Authors:  Zhen Zhang; Anca Selariu; Charles Warden; Grace Huang; Ying Huang; Oluleke Zaccheus; Tong Cheng; Ningshao Xia; Hua Zhu
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

10.  Immunization with the immediate-early tegument protein (open reading frame 62) of varicella-zoster virus protects guinea pigs against virus challenge.

Authors:  C Sabella; P W Lowry; G M Abbruzzi; C M Koropchak; P R Kinchington; M Sadegh-Zadeh; J Hay; W T Ruyechan; A M Arvin
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.